Stocks
Alpha Cognition Inc.ACOG
NASDAQHealthcareBiotechnology$8.31
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing oral therapies for neurodegenerative diseases, with a lead candidate targeting cognitive impairment in Alzheimer's disease and other conditions. Investors track it for its pipeline progress and potential in the Alzheimer's treatment market.
52W Range: $4.50-$10.14
Congressional Interest in Alpha Cognition Inc. (ACOG)
No congressional trades have been disclosed for Alpha Cognition Inc. (ACOG) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ACOG?
No congressional trades found for this stock.